Subacute Budd-Chiari syndrome associated with polycythemia vera and factor V Leiden mutation

Netherlands Journal of Medicine

Volumn 57, Issue 2, 2000, Pages 62-67

  Simsek, S ^a   Verheesen, R V ^a   Haagsma, E B ^b   Lourens, J ^a  

^a Location Alkmaar   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

APC resistance; Budd Chiari syndrome; Myeloproliferative disorder; Thrombosis; Transjugular intrahepatic portosystemic shunt

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; HEPARIN; HYDROXYUREA; ORAL CONTRACEPTIVE AGENT; THIAMAZOLE; THYRAX; UNCLASSIFIED DRUG;

ABDOMINAL DISTENSION; ADULT; ARTICLE; ASCITES FLUID; BUDD CHIARI SYNDROME; CASE REPORT; CHROMOSOME ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; ENDOSCOPY; ESOPHAGUS VARICES; FEMALE; GRAVES DISEASE; HETEROZYGOSITY; HUMAN; HYPERSPLENISM; JAUNDICE; LEG EDEMA; LIVER BIOPSY; LIVER TUMOR; MEGAKARYOCYTE; MUTATION; POLYCYTHEMIA VERA; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; THROMBOCYTOSIS; ULTRASOUND;

ACUTE DISEASE; ASCITES; CONTRACEPTIVES, ORAL; DIAGNOSIS, DIFFERENTIAL; FACTOR V; FEMALE; HEPATIC VEIN THROMBOSIS; HEPATOMEGALY; HUMANS; LIVER; LIVER NEOPLASMS; MIDDLE AGED; MUTATION; POLYCYTHEMIA VERA; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; SPLENOMEGALY; TREATMENT OUTCOME;

EID: 0033931211     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(00)00046-2     Document Type: Article

References (27)

1. Dilawari J.B., Brambery P., Chawla Y., et al. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine. 73:1994;21-35.
2. Sherlock S Dooley J. Budd-Chiari (hepatic venous obstruction) syndrome. Sherlock S., Dooley J. Diseases of the Liver and Biliary System. 1993;183-192 Blackwell Scientific Publications, Oxford.
3. Mahmoud A.E., Mendoza A., Meshikhes A.N., et al. Clinical spectrum, investigations and treatment of Budd-Chiari syndrome. QJM. 89:1996;37-43.
4. Boughton B.J. Hepatic and portal vein thrombosis is closely associated with chronic myeloproliferative disorders. BMJ. 302:1991;192-193.
5. Valla D., Casadevall N., Lacombe C., et al. Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med. 103:1985;329-334.
6. Bertina R.M., Koeleman B.P.C., Koster T., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 369:1994;64-67.
7. 506Gln mutation in factor Va. Lancet. 343:1994;1535-1536.
8. 506 of factor V. Lancet. 343:1994;1536-1537.
9. Zoller B., Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet. 343:1994;1536-1538.
10. Denninger M.H., Beldjord K., Durand F., et al. Budd-Chiari syndrome and factor V leiden mutation. Lancet. 345:1995;525-526.
11. Mahmoud A.E.A., Wilde J.T., Elias E. Budd-Chiari syndrome and factor V leiden mutation. Lancet. 345:1995;526.
12. Blanshard C., Pasi J., Rolles K., et al. Acute Budd-Chiari syndrome treated by liver transplantation in a woman homozygous for factor V Leiden. Eur J Gastroenterol Hepatol. 8:1996;925-927.
13. Fickert P., Ramschak H., Kenner L., et al. Acute Budd-Chiari syndrome with fulminant hepatic failure in a pregnant woman with factor V Leiden mutation. Gastroenterology. 111:1996;1670-1673.
14. Delarive J., Gonvers J.J. Budd-Chiari syndrome related to factor V Leiden mutation. Am J Gastroenterol. 93:1998;651-652.
15. Mahmoud A.E.A., Elias E., Beauchamp N., Wilde J.T. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut. 40:1997;798-800.
16. De Stefano V., Teofili L., Leone G., Michiels J.J. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost. 23:1997;411-418.
17. Panis Y., Belghiti J., Valla D., et al. Portosystemic shunt in Budd-Chiari syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western countries. Surgery. 115:1994;276-281.
18. Blum U., Rossle M., Haag K., et al. Budd-Chiari syndrome: technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt. Radiology. 197:1995;805-811.
19. Kuo P.C., Johnson L.B., Hastings G., et al. Fulminant hepatic failure from the Budd-Chiari syndrome. A bridge to transplatnation with transjugular intrahepatic portosystemic shunt. Transplantation. 62:1996;294-296.
20. Hemming A.W., Langer B., Greig P., et al. Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation. Am J Surg. 171:1996;176-180.
21. Witte A.M., Kool L.J., Veenendaal R., et al. Hepatic vein stenting for Budd-Chiari syndrome. Am J Gastroenterol. 92:1997;498-501.
22. Vandenbroucke J.P., Koster T., Briët E., et al. Increased incidence of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet. 344:1994;1453-1457.
23. Hellgren M., Svenson P.J., Dahlbäck B. Resistance to activated protein C as a basis for thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gynecol. 173:1995;210-213.
24. Muller E.W., De Wolf J.thM., Haagsma E.B. Portal hypertension as presenting feature of a myeloproliferative disorder. Diagnosis and therapeutic dilemmas. Scand J Gastroenterol. 28:(Suppl 200):1993;74-79.
25. Orloff M.J., Girard B. Long term results of treatment of Budd-Chiari syndrome by side to side portocaval shunt. Surg Gynecol Obstet. 168:1989;33-41.
26. Shaked A., Goldstein R.M., Klintmalm G.B., et al. Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome. Surg Gynecol Obstet. 174:1992;453-459.
27. Pisani Ceretti A., Intra M., Prestipino F., et al. Surgical and radiological treatment of primary Budd-Chiari syndrom. World J Surg. 22:1998;48-53.